The critical path to delivering new capacity runs through successful technology transfers between R&D, existing plants, and newly built facilities ( [17] ) ( [18] )
Science 2010
While there may be anecdotal evidence supporting these claims, its essential to examine the scientific research to understand the potential benefits and risks of using B12 injections for purposes beyond deficiency treatment
This figure is directly comparable to the performance of tirzepatide (Mounjaro) in the SURMOUNT-1 trial, which showed approximately 20.9% weight loss at 72 weeks, and exceeds the approximately 14.9% achieved by semaglutide alone in STEP 1
Mounjaro's grand entrance combines the best of both worlds, promising an even more effective performance in managing weight and blood sugar than its predecessors
Research indicates that although semaglutide did not significantly improve hepatic fibrosis, it had positive effects on hepatic steatosis, weight control, and diabetes-related parameters, offering a new therapeutic direction for patients with NASH and compensated cirrhosis (Flint et al., 2021